RxDoctor Payments Data

Taelor Cichanski

Physician Assistant · Atlanta, GANPI 1700470382

Payments from drug & device makers

$6,015in general payments, 2019–2025

Across 309 payments — averaging $19.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$980
  • Lundbeck LLC$621
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$548
  • Otsuka America Pharmaceutical, Inc.$488
  • Johnson & Johnson$455
  • Teva Pharmaceuticals USA, Inc.$451
  • plus $2K from 20 others

What the payments were for

  • Food & beverage$5,95299%
  • Education$621%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,015 in reported general payments places this provider in the 90th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate14$107,415
Invega SustennaPaliperidone Palmitate25$57,504
RexultiBrexpiprazole29$57,440
CaplytaLumateperone Tosylate27$42,172
Abilify MaintenaAripiprazole15$41,570
VraylarCariprazine Hcl24$35,908
TrintellixVortioxetine Hydrobromide24$20,938
Lurasidone Hcl59$10,622
Aripiprazole241$6,688
Vilazodone Hcl50$5,688
Desvenlafaxine Succinate ErDesvenlafaxine Succinate100$5,472
Paliperidone ErPaliperidone45$4,410
Bupropion XlBupropion Hcl169$4,114
Quetiapine Fumarate220$3,807
Duloxetine Hcl184$3,184

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$373$107,41514 claims
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena$488$99,01044 claims
Johnson & JohnsonInvega Sustenna$455$57,50425 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$548$42,17227 claims
AbbVieVraylar$980$35,90824 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$377$20,93824 claims
Lilly USA, LLCOlanzapine$20$2,00560 claims
Almatica Pharma LLCSertraline Hcl$141$676131 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →